Cargando…

miR-126 inhibits papillary thyroid carcinoma growth by targeting LRP6

Detalles Bibliográficos
Autores principales:	Wen, Qiang, Zhao, Jie, Bai, Lin, Wang, Tongtong, Zhang, Haishan, Ma, Qingjie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2021
Materias:	Retraction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8185516/ https://www.ncbi.nlm.nih.gov/pubmed/34080656 http://dx.doi.org/10.3892/or.2021.8097

Ejemplares similares

Function of miR-212 as a tumor suppressor in thyroid cancer by targeting SIRT1
por: Li, Dandan, et al.
Publicado: (2021)

Simultaneous Overexpression of miR-126 and miR-34a Induces a Superior Antitumor Efficacy in Pancreatic Adenocarcinoma [Retraction]
Publicado: (2020)

Retraction: miR-26a and its Target CKS2 Modulate Cell Growth and Tumorigenesis of Papillary Thyroid Carcinoma
Publicado: (2021)

miR-137 acts as a tumor suppressor in papillary thyroid carcinoma by targeting CXCL12
por: Dong, Su, et al.
Publicado: (2021)

miR-622 Suppresses Tumor Formation by Directly Targeting VEGFA in Papillary Thyroid Carcinoma [Retraction]
Publicado: (2021)

LncRNA SNHG16 Drives Proliferation and Invasion of Papillary Thyroid Cancer Through Modulation of miR-497 [Retraction]
Publicado: (2021)

miR-126 and miR-126*: New Players in Cancer
por: Meister, Jeannette, et al.
Publicado: (2010)

Retracted: The Application of Molecular Techniques for Assessment of SOX2 and miR126 Expression as Prognostic Markers in Esophageal Carcinoma
por: Methods in Medicine, Computational and Mathematical
Publicado: (2022)

miR-497 Inhibited Proliferation, Migration and Invasion of Thyroid Papillary Carcinoma Cells by Negatively Regulating YAP1 Expression [Retraction]
Publicado: (2023)

Knockdown of circPVT1 inhibits progression of papillary thyroid carcinoma by sponging miR-126
por: Tao, Ling, et al.
Publicado: (2019)

Curcumin suppresses osteogenesis by inducing miR-126a-3p and subsequently suppressing the WNT/LRP6 pathway
por: Li, Hongling, et al.
Publicado: (2019)

Overexpression of miR-126 Protects Hypoxic-Reoxygenation-Exposed HUVEC Cellular Injury through Regulating LRP6 Expression
por: Sheikh, Md Sayed Ali, et al.
Publicado: (2022)

MiR-126-3p suppresses tumor metastasis and angiogenesis of hepatocellular carcinoma by targeting LRP6 and PIK3R2
por: Du, Chengli, et al.
Publicado: (2014)

miR-622 suppresses tumor formation by directly targeting VEGFA in papillary thyroid carcinoma
por: Wang, Renjie, et al.
Publicado: (2018)

ERK1/2 inhibition reduces vascular calcification by activating miR-126-3p-DKK1/LRP6 pathway
por: Zeng, Peng, et al.
Publicado: (2021)

Correction for: Curcumin suppresses osteogenesis by inducing miR-126a-3p and subsequently suppressing the WNT/LRP6 pathway
por: Li, Hongling, et al.
Publicado: (2021)

miR-138 inhibits gastric cancer growth by suppressing SOX4
por: Pang, Lei, et al.
Publicado: (2022)

Synthetic miR-145 mimic inhibits multiple myeloma cell growth in vitro and in vivo
por: Zhang, Qi, et al.
Publicado: (2021)

Retraction Notice to: circRASSF2 Acts as ceRNA and Promotes Papillary Thyroid Carcinoma Progression through miR-1178/TLR4 Signaling Pathway
por: Wu, Guojun, et al.
Publicado: (2021)

MiR-126 Regulates Proliferation and Invasion in the Bladder Cancer BLS Cell Line by Targeting the PIK3R2-Mediated PI3K/Akt Signaling Pathway [Retraction]
Publicado: (2021)

LncRNA SNHG16 drives proliferation and invasion of papillary thyroid cancer through modulation of miR-497
por: Wen, Qiang, et al.
Publicado: (2019)

miR-365 targets ADAM10 and suppresses the cell growth and metastasis of hepatocellular carcinoma
por: Liu, Yahui, et al.
Publicado: (2022)

MicroRNA-509 targets PAX6 to inhibit cell proliferation and invasion in papillary thyroid carcinoma
por: Zhang, Shuilong, et al.
Publicado: (2022)

Retraction Note: Endothelial progenitor cell-derived exosomes, loaded with miR-126, promoted deep vein thrombosis resolution and recanalization
por: Sun, Jiacheng, et al.
Publicado: (2019)

miR-126-3p Inhibits Thyroid Cancer Cell Growth and Metastasis, and Is Associated with Aggressive Thyroid Cancer
por: Xiong, Yin, et al.
Publicado: (2015)

miR-133a inhibits cervical cancer growth by targeting EGFR
por: Song, Xuesong, et al.
Publicado: (2021)

Retraction: miR-126a-3p induces proliferation, migration and invasion of trophoblast cells in preeclampsia-like rats through inhibiting a disintegrin and metalloprotease 9(ADAM9)
Publicado: (2020)

MiR-126 and miR-126* regulate shear-resistant firm leukocyte adhesion to human brain endothelium
por: Cerutti, Camilla, et al.
Publicado: (2017)

[Retracted] Exosomal miR‑130a‑3p promotes the progression of differentiated thyroid cancer by targeting insulin‑like growth factor 1
por: Yin, Guang, et al.
Publicado: (2023)

Retracted: Analysis on Value of Applying Serum miR-144 and miR-221 Levels in Diagnosing Atherosclerosis
por: Engineering, Journal of Healthcare
Publicado: (2023)

Expression and correlation of miR-124 and miR-126 in breast cancer
por: Li, Fanfan
Publicado: (2019)

Hypoxia-Induced miR-137 Inhibition Increased Glioblastoma Multiforme Growth and Chemoresistance Through LRP6
por: Li, Dong-Mei, et al.
Publicado: (2021)

Retracted: miR-196a-2 Promotes Malignant Progression of Thyroid Carcinoma by Targeting NRXN1
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

Involvement of miR-126 in autoimmune disorders
por: Casciaro, Marco, et al.
Publicado: (2018)

MiR-126 in intestinal-type sinonasal adenocarcinomas: exosomal transfer of MiR-126 promotes anti-tumour responses
por: Tomasetti, Marco, et al.
Publicado: (2018)

Retracted: Clinical Potential of miR-451 and miR-506 as a Prognostic Biomarker in Patients with Breast Cancer
por: Healthcare Engineering, Journal of
Publicado: (2023)

Retraction: The Tumor Suppressor Role of miR-124 in Osteosarcoma
por: Geng, Shuo, et al.
Publicado: (2019)

[Retracted] miR‑187 inhibits the growth of cervical cancer cells by targeting FGF9
por: Liang, Hua, et al.
Publicado: (2023)

miR-222 regulates sorafenib resistance and enhance tumorigenicity in hepatocellular carcinoma
por: Liu, Kai, et al.
Publicado: (2021)

Retraction: Diagnostic Valuation of Serum miR-184 and miR-191 in Patients With Non-Small-Cell Lung Cancer
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_biijsqvrcc3s5mb0bq3a8bf3ng